S054 Dermatology Review: Skin Cancer, Surgical, and Cosmetic
DESCRIPTION
In the cosmetic portion of this course, we will evaluate how to optimize the use of various non-ablative technologies including radiofrequency, micro-focused ultrasound, and non-ablative fractionated laser. We will review patient selection, setting patient expectations, best practices in regards to treatment parameters.
For the general dermatologic surgery component of the session we will have two round-table discussion groups. In the first group, physicians early in their practice will discuss aspects of their early practice experience including: good advice or principles that grew their practice, efficiencies/tips and pearls, mistakes, or missed opportunities. In the second group, there will be a round-table from mature practices on developing their role so that they maximize joy in what they do. Also what changes have they implemented over their years of practice which have made the biggest difference.
LEARNING OBJECTIVES
Compare and describe non-ablative laser technologies. Demonstrate best practices for obtaining a natural result. Discuss optimum patient parameters.
Recognize potential pitfalls and locate opportunities in a beginning surgical practice. Describe helpful strategies to develop a practice that meets your goals.
Reflect and identify choices made through the career path that improved the value of both your day to day experience and helped you to define and complete goals in your practice.
SCHEDULE
9:00 AM
Intro
Naomi Lawrence, MD, FAAD
9:05 AM
"Skin Quality and Tightening": Ultherapy, RF, Sofwave
Ardalan Minokadeh, MD, PhD, FAAD
9:20 AM
"Wrinkles, Texture, Scarring": Fractional 1550nm (Fraxel, Icon, Moxi), 1927nm (Fraxel Dual, LaseMD, etc), RF/RF microneedling
Isabela Tollini Jones, MD, FAAD
9:35 AM
"Color Correction" (Pigment, Redness): IPL, PDL, KTP, LED, Q-switched/picosecond lasers
Girish S. Munavalli, MD, MHS, FAAD
9:50 AM
Q&A
Naomi Lawrence, MD, FAAD, Isabela Tollini Jones, MD, FAAD, Ardalan Minokadeh, MD, PhD, FAAD, Girish S. Munavalli, MD, MHS, FAAD
10:00 AM
Advice for the first ten years of surgical practice; mistakes/missed opportunities, efficiencies, tips, and pearls
Tara S. Jennings, MD, FAAD
10:15 AM
Advice for the first ten years of surgical practice; mistakes/missed opportunities, efficiencies, tips, and pearls
Michael Albert Renzi, MD, FAAD
10:30 AM
Advice for the first ten years of surgical practice; mistakes/missed opportunities, efficiencies, tips, and pearls
10:45 AM
Advice for the first ten years of surgical practice; mistakes/missed opportunities, efficiencies, tips, and pearls Q&A
Alexander Valiga, MD, FAAD
11:00 AM
Q&A
Michael Albert Renzi, MD, FAAD, Alexander Valiga, MD, FAAD, Naomi Lawrence, MD, FAAD, Tara S. Jennings, MD, FAAD
11:10 AM
Advice for the mature private cosmetic practice
Cheryl M. Burgess, MD, FAAD
11:25 AM
Advice for the mature private Mohs practice
Ryan W. Ahern, MD, FAAD
11:40 AM
Advice for the mature academic surgical practice
Naomi Lawrence, MD, FAAD
11:55 AM
Q&A/discussion
Naomi Lawrence, MD, FAAD, Ryan W. Ahern, MD, FAAD, Cheryl M. Burgess, MD, FAAD
DIRECTOR
Naomi Lawrence, MD, FAAD
SPEAKERS
Ryan W. Ahern, MD, FAAD
Cheryl M. Burgess, MD, FAAD
Tara S. Jennings, MD, FAAD
Isabela Tollini Jones, MD, FAAD
Yesul Kim, MD, FAAD
Ardalan Minokadeh, MD, PhD, FAAD
Girish S. Munavalli, MD, MHS, FAAD
Michael Albert Renzi, MD, FAAD
Alexander Valiga, MD, FAAD
DISCLOSURES
Ryan W. Ahern, MD, FAAD
No financial relationships exist with ineligible companies.
Cheryl M. Burgess, MD, FAAD
Aerolase – Investigator(Equipment); Allergan, Inc. – Investigator(Grants/Research Funding), Stockholder(Stock); Janssen Pharmaceuticals, Inc – Investigator(Grants/Research Funding); Merz Aesthetics – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Prollenium – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Target Cool – Advisory Board(Equipment); TEOXANE Laboratories – Investigator(Grants/Research Funding);
Tara S. Jennings, MD, FAAD
No financial relationships exist with ineligible companies.
Isabela Tollini Jones, MD, FAAD
No financial relationships exist with ineligible companies.
Yesul Kim, MD, FAAD
No financial relationships exist with ineligible companies.
Naomi Lawrence, MD, FAAD
No financial relationships exist with ineligible companies.
Ardalan Minokadeh, MD, PhD, FAAD
Allergan Aesthetics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Evolus, Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Galderma – Investigator(Grants/Research Funding); Merz Aesthetics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding), Speaker/Faculty Education(Honoraria); Silk Medical Aesthetics Inc. – Investigator(Grants/Research Funding); symatese – Investigator(Grants/Research Funding); VeraDermics Inc. – Advisory Board(Honoraria);
Girish S. Munavalli, MD, MHS, FAAD
AbbVie – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Honoraria); Lumenis – Investigator(Equipment); Sofwave – Investigator(Stock Options);
Michael Albert Renzi, MD, FAAD
No financial relationships exist with ineligible companies.
Alexander Valiga, MD, FAAD
No financial relationships exist with ineligible companies.